ViaDerma, Inc. (OTC Pink: VDRM) is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development.
Our products are applied topically to the skin using our patent-pending SkinPassTM delivery system technology.
Our first aid and topical antibiotic products are used within the OTC drug market, i.e. non-prescription. ViaDerma believes the delivery system can be used for the topical drug market and also to turn certain oral medications into topically based medications.
In addition to the primary plan of developing and selling new products to the market, ViaDerma is exploring the possibility of licensing our SkinPassTM technology to other industry leading pharmaceutical companies around the world.
Latest financial disclosures available here on: OTC Markets
For investor enquiries, please contact us at ir@viaderma.com.